Metabolic Differences between CSII and MDI in Type 1 Diabetes Mexican Patients from the Multicentric Study RENACED

被引:0
|
作者
Faradji, Raquel N.
Valenzuela-Lara, Marisol
Bustamante-Martinez, Jorge F.
Cecena-Gonzalez, Martha P.
De la Garza-Hernandez, Natalia E.
Escobedo-Ortiz, Ana
Ferreira Hermosillo, Aldo
Figueroa-Andrade, Mario H.
Flores-Camargo, Areli
Garcia-Manzanarez, Raquel
Gomez-Cruz, Jose R.
Gonzalez-Galvez, Guillermo
Islas-Ortega, Laura
Lopez-Miramontes, Claudia
Martinez-Ramos, Angelica
Mendoza-Romo, Miguel A.
Miracle-Lopez, Sigfrido
Polanco-Preza, Miguel A.
Rangel-Guerrero, Hugo G.
Rodriguez-Sanchez, Ester
Romero-Zazueta, Alejandro
Tavera-Hernandez, Marcela
Valenzuela-Montoya, Julio C.
Vidrio-Velazquez, Maricela
Yepez-Rodriguez, Alicia E.
Nino-Vargas, Ricardo S.
Sainz De la Maza-Viadero, Maria E.
Magis-Rodriguez, Carlos
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
128-LB
引用
收藏
页码:LB33 / LB34
页数:2
相关论文
共 50 条
  • [1] Results of the Multicentric Study RENACED on Type 1 Diabetes Mexican Patients
    Faradji, Raquel N.
    Valenzuela-Lara, Marisol
    Bustamante-Martinez, Jorge F.
    Cecena-Gonzalez, Martha P.
    De la Garza-Hernandez, Natalia E.
    Escobedo-Ortiz, Ana
    Hermosillo, Aldo Ferreira
    Figueroa-Andrade, Mario H.
    Flores-Camargo, Areli
    Garcia-Manzanarez, Raquel
    Gomez-Cruz, Jose R.
    Laura Islas-Ortega, Guillermo Gonzalez-Galvez
    Lopez-Miramontes, Claudia
    Martinez-Ramos, Angelica
    Mendoza-Romo, Miguel A.
    Miracle-Lopez, Sigfrido
    Polanco-Preza, Miguel A.
    Rangel-Guerrero, Hugo G.
    Rodriguez-Sanchez, Ester
    Romero-Zazueta, Alejandro
    Tavera-Hernandez, Marcela
    Valenzuela-Montoya, Julio C.
    Vidrio-Velazquez, Maricela
    Yepez-Rodriguez, Alicia E.
    Nino-Vargas, Ricardo S.
    Sainz De la Mazaviadero, Maria E.
    Magis-Rodriguez, Carlos
    [J]. DIABETES, 2017, 66 : LB65 - LB65
  • [2] EVALUATION OF TREATMENT SATISFACTION IN PATIENTS WITH TYPE 1 DIABETES USING CSII AND MDI
    Cander, S.
    Gul, O. Oz
    Deligonul, A.
    Ersoy, C.
    Erturk, E.
    Tuncel, E.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A35 - A36
  • [3] MDI VS CSII IN PREGNANCY WITH TYPE1 DIABETES
    Torlone, E.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A12 - A13
  • [4] Vascular Health in Type 1 Diabetes: CSII vs. MDI
    Januszewski, Andrzej S.
    Karschimkus, Connie
    Mcauley, Sybil
    O'Neal, David N.
    Jenkins, Alicia J.
    [J]. DIABETES, 2012, 61 : A228 - A228
  • [5] CGM combined with either MDI or CSII is superior to standalone MDI or CSII in type 1 diabetes: 2 years of follow-up in the COMISAIR study
    Soupal, J.
    Petruzelkova, L.
    Flekac, M.
    Dankova, M.
    Haskova, A.
    Matoulek, M.
    Mikes, O.
    Pelcl, T.
    Skrha, J.
    Svacina, S.
    Prazny, M.
    [J]. DIABETOLOGIA, 2017, 60 : S328 - S329
  • [6] Trends in the treatment of type 1 diabetes with CSII vs MDI: a Canadian retrospective observational study
    Terres, J. Alfonso Ross
    Jabbour, A. D.
    Freeman, M. A.
    [J]. DIABETOLOGIA, 2012, 55 : S422 - S422
  • [7] Transitioning patients with type 1 diabetes from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII)
    Kumar, RP
    Hirsch, IB
    [J]. DIABETES, 2004, 53 : A110 - A110
  • [8] Pregnancy outcome and glycemic control in women with type 1 diabetes: A retrospective comparison between CSII and MDI treatment
    Talaviya, Praful A.
    Saboo, Banshi D.
    Joshi, Shashank R.
    Padhiyar, Jayendra N.
    Chandarana, Hardik K.
    Shah, Smita J.
    Vyas, Chintal K.
    Shah, Asha N.
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2013, 7 (02) : 68 - 71
  • [9] SHORT TERM GLYCAEMIC VARIABILITY IN CSII VS MDI IN ADULTS WITH TYPE 1 DIABETES
    Scott, E. S.
    McGrath, R. T.
    Januszewski, A. S.
    Fulcher, G. R.
    Jenkins, A. J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A129 - A130
  • [10] CARDIOVASCULAR RISK ASSESSMENT IN PEOPLE LIVING WITH TYPE 1 DIABETES FROM THE RENACED-DT1 MEXICAN REGISTRY
    Almeda-Valdes, P.
    Antonio-Villa, N.
    Garcia-Tuomola, A.
    Vidrio-Velazquez, M.
    Islas-Ortega, L.
    Bustamante-Martinez, J.
    Martinez-Ramos Mendez, A.
    De la Garza-Hernandez, N.
    Gonzalez-Galvez, G.
    Valadez-Capetillo, M.
    Sanchez-Ruiz, K.
    Castillo-Galindo, C.
    Yepez-Rodriguez, A.
    Polanco-Preza, M.
    Faradji, R.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A123 - A123